PLL Therapeutics reports positive phase I/II data for gut-targeting ALS therapy The French biopharmaceutical company, PLL Therapeutics, announced positive results from a phase I/II clinical trial for its investigational therapy PLL001 to treat amyotrophic... See more
William Smith, a graduate student at University of St. Andrews, normally studies how Drosophila controls their movements in Stefan Pulver’s lab. But in the midst of calcium imaging and electrophysiology experiments, he wondered how much his work was impac... See more
30 January 2026
HSUHK’s Creative Humanities Hub has been awarded the BEAM Plus New Building (Version 2.0) Final Platinum Certification by the Hong Kong Green Building Council, the highest rating recognising sustainable construction. This recognition also ... See more
Imagine getting intoxicated without drinking a drop of alcohol. This is what happens in people with auto-brewery syndrome (ABS), where microbes in the gut produce alcohol that then becomes absorbed into the blood stream at high levels. It's a rare conditi... See more
22 January 2026
On 22 January 2026, the Centre for Teaching and Learning, in collaboration with the Student Affairs Office, organised the interactive workshop “Riding on the ADHD Learning Curve”. The event enhanced academic and administrative staff’s unde... See more
